"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 9 | 9 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 10 | 10 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 15 | 15 |
| 2001 | 0 | 15 | 15 |
| 2002 | 0 | 20 | 20 |
| 2003 | 0 | 21 | 21 |
| 2004 | 0 | 31 | 31 |
| 2005 | 0 | 33 | 33 |
| 2006 | 0 | 45 | 45 |
| 2007 | 1 | 33 | 34 |
| 2008 | 0 | 38 | 38 |
| 2009 | 2 | 51 | 53 |
| 2010 | 3 | 45 | 48 |
| 2011 | 3 | 49 | 52 |
| 2012 | 2 | 57 | 59 |
| 2013 | 2 | 44 | 46 |
| 2014 | 4 | 54 | 58 |
| 2015 | 6 | 65 | 71 |
| 2016 | 4 | 57 | 61 |
| 2017 | 7 | 61 | 68 |
| 2018 | 11 | 68 | 79 |
| 2019 | 4 | 72 | 76 |
| 2020 | 5 | 55 | 60 |
| 2021 | 5 | 39 | 44 |
| 2022 | 1 | 24 | 25 |
| 2023 | 0 | 38 | 38 |
| 2024 | 13 | 20 | 33 |
| 2025 | 2 | 47 | 49 |
| 2026 | 2 | 19 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker. Neurology. 2026 Oct 13; 107(7):e218519.
-
Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial. Ann Neurol. 2026 Oct; 100(4):793-807.
-
Risk profile and prognostic implications of premature advanced coronary atherosclerotic disease among young to early middle-aged adults: the coronary artery calcium consortium. Eur J Prev Cardiol. 2026 Jul 14; 33(9):1621-1628.
-
Moderate to severe negative symptoms predict low risk of symptoms worsening in schizophrenia patients in CATIE. Schizophr Res. 2026 Sep; 295:150-155.
-
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms. Blood Adv. 2026 05 26; 10(10):3746-3755.
-
The Natural History of Residual and Recurrent Disease in Advanced Juvenile Nasopharyngeal Angiofibroma: A Systematic Review. Laryngoscope. 2026 Oct; 136(10):4130-4138.
-
Inflammation-Induced Claudin-2 Up-Regulation Limits Pancreatitis Development by Enhancing Pancreatic Ductal Transport. Gastroenterology. 2026 Oct; 171(4):699-716.
-
Tissue-specific tolerance mechanisms and lymph node co-drainage shape T cell immunity in the upper digestive system and pancreatic cancer progression. Cell Rep. 2026 May 26; 45(5):117324.
-
Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2026 May 01; 23(5):667-688.
-
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS. Alzheimers Dement. 2026 May; 22(5):e71492.